CDNA CareDx, Inc. - Common Stock

NASDAQ · Biotechnology · Ver en SEC EDGAR ↗
$20,89
Precio · May 20, 2026
Fundamentales a fecha de Abr 28, 2026

CDNA Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas

Precio
$20.89
Capitalización Bursátil
$959M
P/E (TTM)
-47.1
BPA (TTM)
$-0.40
Ingresos (TTM)
$380M
Rendimiento div.
ROE
-6.8%
Deuda/Capital
Rango 52S
$11 – $23

CDNA Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista

Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA

Ingresos y Beneficio Neto $380M
9-point trend, +686.0%
2017-12-31 2025-12-31
BPA $-0.40
9-point trend, +83.2%
2017-12-31 2025-12-31
Flujo de caja libre
2-point trend, +58.3%
2017-12-31 2018-12-31
Márgenes -5.6%
2019-12-31 2019-12-31

Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?

Métrica
Tendencia a 5 años
CDNA
Mediana de Pares
P/E (TTM)
5-point trend, +38.9%
-47.1
15.9
P/S (TTM) (P/V (TTM))
5-point trend, -68.9%
2.5
93.9
P/B (P/C)
5-point trend, -38.7%
3.2
3.6

Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC

Métrica
Tendencia a 5 años
CDNA
Mediana de Pares
Operating Margin (Margen Operativo)
5-point trend, +19.2%
-8.1%
Net Profit Margin (Margen de Beneficio Neto)
5-point trend, +45.6%
-5.6%
-359.6%
ROA
5-point trend, +28.0%
-4.7%
-51.4%
ROE
5-point trend, -4.5%
-6.8%
-55.8%
ROIC
5-point trend, -68.7%
-10.3%

Salud financiera Deuda, liquidez, solvencia — solidez del balance general

Métrica
Tendencia a 5 años
CDNA
Mediana de Pares
Current Ratio (Ratio corriente)
5-point trend, -49.0%
2.9
9.0
Quick Ratio (Ratio Rápido)
5-point trend, -53.7%
2.4

Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años

Métrica
Tendencia a 5 años
CDNA
Mediana de Pares
Revenue YoY (Ingresos interanuales)
5-point trend, +28.1%
13.8%
Revenue CAGR 3Y (Ingresos CAGR 3A)
5-point trend, +28.1%
5.7%
Revenue CAGR 5Y (Ingresos CAGR 5A)
5-point trend, +28.1%
14.6%

Métricas por acción BPA, valor contable por acción, flujo de caja por acción, dividendo por acción

Métrica
Tendencia a 5 años
CDNA
Mediana de Pares
EPS (Diluted) (BPA (Diluido))
5-point trend, +32.2%
$-0.40

Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar

Métrica
Tendencia a 5 años
CDNA
Mediana de Pares

CDNA Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista

COMPRA 14 analistas
  • Compra fuerte 5 35,7%
  • Compra 4 28,6%
  • Mantener 5 35,7%
  • Venta 0 0,0%
  • Venta fuerte 0 0,0%

Precio objetivo a 12 meses

5 analistas · 2026-05-15
Objetivo mediano $26.00 +24,4%
Objetivo medio $25.80 +23,5%

Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados

Sorpresa Media
0.04%
Período EPS Actual EPS est. Sorpresa
31 de marzo de 2026 $0.34 $0.14 0.20%
31 de diciembre de 2025 $0.12 $0.24 -0.12%
30 de septiembre de 2025 $0.28 $0.14 0.14%
30 de junio de 2025 $0.10 $0.12 -0.02%
31 de marzo de 2025 $0.09 $0.07 0.02%

Comparación con pares Métricas clave frente a competidores del sector

Ticker Capitalización Bursátil P/E Ingresos interanuales Margen Neto ROE Margen Bruto
CDNA $959M -47.1 13.8% -5.6% -6.8%
OLMA $2.03B -13.4 -39.4%
MPLT $773M -0.9 -151.1%
ZBIO $1.98B -4.3 100.0% -3777.4% -156.8%
JBIO $761M -4.8 -47.7%
PURR
AKTS
CRVS $575M -14.5 -21.6%
SVRA $1.23B -11.4 -73.4%
MNKD $1.75B 283.5 22.2% 1.7% -11.1%

Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja

Estado de resultados 16
Datos anuales de Estado de resultados para CDNA
Métrica Tendencia 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +1290.9% $380M $334M $280M $322M $296M $192M $127M $77M $48M $41M $28M $27M
Cost of Revenue 6-point trend, +45455000.00 · · · · · · $45M $33M $21M $10M $0 $0
Gross Profit 3-point trend, +202.8% · · · · · · $82M $44M $27M · · ·
R&D Expense 12-point trend, +1757.2% $71M $73M $82M $90M $77M $49M $31M $15M $12M $12M $9M $4M
SG&A Expense 12-point trend, +1175.1% $108M $125M $119M $100M $75M $49M $37M $23M $20M $21M $12M $8M
Operating Expenses 12-point trend, +1475.8% $411M $293M $484M $399M $326M $215M $152M $92M $47M $78M $40M $26M
Operating Income 12-point trend, -2562.5% $-31M $41M $-203M $-77M $-30M $-23M $-25M $-16M $-20M $-37M $-12M $1M
Other Non-op 12-point trend, +771.8% $524.0K $329.0K $1M $-3M $-3M $-811.0K $-719.0K $-178.0K $-1M $-2M $-188.0K $-78.0K
Pretax Income 12-point trend, -2832.3% $-21M $53M $-190M $-76M $-32M $-20M $-24M $-48M $-57M $-41M $-14M $-719.0K
Income Tax 12-point trend, +118.1% $271.0K $310.0K $141.0K $379.0K $-1M $-1M $-2M $-1M $-2M $-2M $0 $-2M
Net Income 12-point trend, -2834.2% $-21M $53M $-190M $-77M $-31M $-19M $-22M $-47M $-55M $-39M $-14M $781.0K
EPS (Basic) 12-point trend, -407.7% $-0.40 $1.00 $-3.54 $-1.44 $-0.59 $-0.40 $-0.52 $-1.31 $-2.38 $-2.39 $-1.16 $0.13
EPS (Diluted) 12-point trend, -500.0% $-0.40 $0.93 $-3.54 $-1.44 $-0.59 $-0.40 $-0.52 $-1.31 $-2.38 $-2.39 $-1.16 $0.10
Shares (Basic) 12-point trend, +816.2% 53,287,546 52,773,247 53,764,705 53,321,625 52,241,076 46,481,772 42,151,617 35,638,956 23,332,503 16,496,911 11,860,885 5,815,928
Shares (Diluted) 12-point trend, +474.0% 53,287,546 56,620,590 53,764,705 53,321,625 52,241,076 46,481,772 42,151,617 35,638,956 23,332,503 16,496,911 11,860,885 9,283,001
EBITDA 10-point trend, -994.6% $-16M $55M $-189M $-77M $-30M $-23M $-25M $-16M $-20M · · $2M
Balance general 28
Datos anuales de Balance general para CDNA
Métrica Tendencia 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +79.6% $65M $115M $82M $90M $348M $135M $38M $65M $17M $17M $30M $36M
Short-term Investments 7-point trend, +111779000.00 $112M $146M $153M $203M $0 $90M $0 · · · · ·
Receivables 10-point trend, +1440.0% $43M $65M $51M $66M $60M $35M $24M $10M $3M $3M · ·
Inventory 12-point trend, +3792.9% $27M $20M $19M $19M $17M $10M $6M $5M $6M $5M $766.0K $686.0K
Prepaid Expense 12-point trend, +1854.1% $11M $7M $8M $9M $8M $4M $4M $2M $1M $1M $1M $542.0K
Current Assets 12-point trend, +537.3% $257M $352M $314M $388M $433M $273M $72M $81M $27M $27M $34M $40M
PP&E (Net) 12-point trend, +1575.4% $33M $34M $35M $36M $22M $11M $4M $4M $2M $3M $2M $2M
PP&E (Gross) 5-point trend, +39.6% · · · · · · · $18M $18M $17M $14M $13M
Accum. Depreciation 5-point trend, +27.1% · · · · · · · $14M $15M $14M $12M $11M
Goodwill 12-point trend, +236.0% $40M $40M $40M $38M $37M $24M $24M $12M $12M $14M $12M $12M
Intangibles 12-point trend, +380.6% $32M $38M $46M $43M $50M $44M $46M $33M $33M $33M $7M $7M
Other Non-current Assets 12-point trend, +13312.0% $3M $2M $1M $4M $6M $1M $1M $0 $0 $20.0K $49.0K $25.0K
Total Assets 12-point trend, +575.9% $413M $491M $467M $543M $567M $369M $152M $131M $84M $77M $56M $61M
Accounts Payable 12-point trend, +785.5% $10M $8M $13M $10M $13M $10M $6M $5M $3M $3M $2M $1M
Current Liabilities 12-point trend, +706.9% $90M $89M $78M $76M $77M $69M $35M $20M $43M $41M $10M $11M
Capital Leases 12-point trend, +18465.1% $20M $22M $28M $33M $17M $16M $2M $249.0K $14.0K $26.0K $57.0K $106.0K
Deferred Tax 11-point trend, +181000.00 $181.0K $164.0K $136.0K $0 $415.0K $1M $2M $3M $5M $6M $0 ·
Other Non-current Liabilities 12-point trend, +1392.9% $418.0K $645.0K $97M $249.0K $455.0K $240.0K $2M $2M $1M $1M $28.0K $28.0K
Total Liabilities 12-point trend, +455.0% $110M $113M $205M $112M $101M $91M $53M $35M $90M $57M $26M $20M
Long-term Debt 7-point trend, -100.0% · · · · · $0 $0 $0 $34M $24M $16M $11M
Total Debt 5-point trend, -100.0% · · · · · $0 $0 $0 $34M · · $11M
Common Stock 12-point trend, +316.7% $50.0K $51.0K $49.0K $52.0K $52.0K $49.0K $42.0K $41.0K $29.0K $21.0K $12.0K $12.0K
Paid-in Capital 3-point trend, +17.4% · · · · · · · · · $236M $203M $201M
Retained Earnings 12-point trend, -361.4% $-735M $-626M $-678M $-460M $-383M $-353M $-334M $-312M $-268M $-213M $-173M $-159M
AOCI 11-point trend, -5515000.00 $-6M $-9M $-7M $-8M $-5M $-2M $-5M $-4M $-2M $-4M $0 ·
Stockholders' Equity 12-point trend, +633.9% $303M $378M $261M $431M $466M $278M $99M $96M $-6M $19M $29M $41M
Liabilities + Equity 12-point trend, +575.9% $413M $491M $467M $543M $567M $369M $152M $131M $84M $77M $56M $61M
Shares Outstanding 12-point trend, +331.4% 50,916,644 54,771,203 51,503,377 53,533,250 52,923,360 49,441,166 42,498,430 41,384,960 28,825,019 21,278,373 11,902,363 11,803,970
Flujo de Efectivo 16
Datos anuales de Flujo de Efectivo para CDNA
Métrica Tendencia 202520242023202220212020201920182017201620152014
D&A 12-point trend, +2833.2% $15M $14M $14M $12M $9M $7M $6M $4M $4M $3M $796.0K $512.0K
Stock-based Comp 12-point trend, +6416.6% $35M $66M $49M $47M $36M $23M $22M $7M $2M $2M $1M $535.0K
Deferred Tax 12-point trend, +90.1% $-149.0K $101.0K $72.0K $-278.0K $-1M $-1M $-1M $-2M $-2M $-2M $0 $-2M
Amort. of Intangibles 11-point trend, +6351000.00 $6M $6M $6M $6M $6M $5M $4M $2M $3M $2M $0 ·
Restructuring 4-point trend, +1783000.00 · $2M $2M $0 $0 · · · · · · ·
Other Non-cash 4-point trend, +363.7% $14M $-95M $108M · · · · · · · · $-5M
Operating Cash Flow 12-point trend, +1354.7% $42M $38M $-18M $-25M $-19M $33M $-3M $-4M $-14M $-17M $-10M $-3M
CapEx 5-point trend, +177.6% · · · · · · · $2M $186.0K $549.0K $1M $733.0K
Investing Cash Flow 10-point trend, +110.2% $2M $-483.0K $40M $-229M $48M $-100M $-23M $-8M $-6M $-21M · ·
Stock Issued 3-point trend, -100.0% · · $0 $0 $189M · · · · · · ·
Stock Repurchased 6-point trend, +87768000.00 $88M $522.0K $28M $642.0K $0 $0 · · · · · ·
Net Stock Activity 4-point trend, -13571.0% $-88M $-522.0K $-28M $-642.0K · · · · · · · ·
Financing Cash Flow 10-point trend, -474.7% $-93M $-6M $-30M $-5M $186M $163M $-132.0K $50M $29M $25M · ·
Net Change in Cash 12-point trend, -257.5% $-49M $32M $-8M $-258M $214M $96M $-26M $38M $9M $-13M $-7M $31M
Taxes Paid 8-point trend, +284000.00 $284.0K $317.0K $738.0K $392.0K $14.0K $80.0K $0 $0 · · · ·
Free Cash Flow 3-point trend, -48.0% · · · · · · · $-6M $-14M · · $-4M
Rentabilidad 8
Datos anuales de Rentabilidad para CDNA
Métrica Tendencia 202520242023202220212020201920182017201620152014
Gross Margin · · · · · · 64.2% · · · · ·
Operating Margin 10-point trend, -276.9% -8.1% 12.2% -72.5% -24.0% -10.0% -11.7% -19.3% -20.3% -42.0% · · 4.6%
Net Margin 10-point trend, -296.5% -5.6% 15.7% -67.9% -23.8% -10.3% -9.7% -17.3% -61.1% -114.8% · · 2.9%
Pretax Margin 10-point trend, -111.0% -5.5% 15.8% -67.8% -23.7% -10.8% -10.3% -18.9% -63.0% -118.5% · · -2.6%
EBITDA Margin 10-point trend, -164.3% -4.2% 16.5% -67.4% -24.0% -10.0% -11.7% -19.3% -20.3% -42.0% · · 6.5%
ROA 10-point trend, -314.5% -4.7% 11.0% -37.7% -13.8% -6.6% -7.2% -15.6% -43.6% -69.9% · · 2.2%
ROE 10-point trend, -373.4% -6.8% 16.1% -58.1% -17.1% -6.5% -6.9% -22.4% -104.1% -831.1% · · -1.4%
ROIC 10-point trend, -298.8% -10.3% 10.7% -77.9% -18.0% -6.1% -7.7% -22.7% -15.8% -70.5% · · -2.6%
Liquidez y Solvencia 4
Datos anuales de Liquidez y Solvencia para CDNA
Métrica Tendencia 202520242023202220212020201920182017201620152014
Current Ratio 10-point trend, -21.0% 2.9 3.9 4.0 5.1 5.6 3.9 2.1 4.2 0.6 · · 3.6
Quick Ratio 10-point trend, -25.2% 2.4 3.6 3.7 4.7 5.3 3.7 1.8 3.8 0.5 · · 3.3
Debt / Equity 5-point trend, -100.0% · · · · · 0.0 0.0 0.0 -5.6 · · 0.3
LT Debt / Equity 5-point trend, -100.0% · · · · · 0.0 0.0 0.0 -3.0 · · 0.1
Eficiencia 3
Datos anuales de Eficiencia para CDNA
Métrica Tendencia 202520242023202220212020201920182017201620152014
Asset Turnover 10-point trend, +9.2% 0.8 0.7 0.6 0.6 0.6 0.7 0.9 0.7 0.6 · · 0.8
Inventory Turnover 3-point trend, -41.5% · · · · · · 8.3 · 1.6 · · 14.2
Receivables Turnover 9-point trend, -57.8% 7.1 5.8 4.8 5.1 6.3 6.6 7.5 12.0 16.8 · · ·
Por Acción 5
Datos anuales de Por Acción para CDNA
Métrica Tendencia 202520242023202220212020201920182017201620152014
Book Value / Share 10-point trend, +70.1% $5.95 $6.91 $5.07 $8.05 $8.80 $5.62 $2.33 $2.32 $-0.21 · · $3.50
Revenue / Share 10-point trend, +142.3% $7.13 $5.90 $5.21 $6.03 $5.67 $4.13 $3.01 $2.15 $2.07 · · $2.94
Cash Flow / Share 10-point trend, +318.6% $0.79 $0.67 $-0.34 $-0.47 $-0.37 $0.72 $-0.07 $-0.11 $-0.61 · · $-0.36
Cash / Share 10-point trend, -58.4% $1.28 $2.09 $1.60 $1.68 $6.58 $2.72 $0.90 $1.56 $0.59 · · $3.09
EPS (TTM) 12-point trend, -500.0% $-0.40 $0.93 $-3.54 $-1.44 $-0.59 $-0.40 $-0.52 $-1.31 $-2.38 $-2.39 $-1.16 $0.10
Tasas de Crecimiento 3
Datos anuales de Tasas de Crecimiento para CDNA
Métrica Tendencia 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, -74.6% 13.8% 19.1% -12.9% 8.6% 54.2% · · · · · · ·
Revenue CAGR 3Y 3-point trend, -57.6% 5.7% 4.0% 13.4% · · · · · · · · ·
Revenue CAGR 5Y 14.6% · · · · · · · · · · ·
Valoración (TTM) 14
Datos anuales de Valoración (TTM) para CDNA
Métrica Tendencia 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +1290.9% $380M $334M $280M $322M $296M $192M $127M $77M $48M $41M $28M $27M
Net Income TTM 12-point trend, -2834.2% $-21M $53M $-190M $-77M $-31M $-19M $-22M $-47M $-55M $-39M $-14M $781.0K
Market Cap 10-point trend, +1020.9% $959M $1.17B $618M $611M $2.41B $3.58B $917M $1.04B $212M · · $86M
Enterprise Value 5-point trend, +5443.8% · · · · · $3.36B $878M $976M $229M · · $61M
P/E 12-point trend, -165.0% -47.1 23.0 -3.4 -7.9 -77.1 -181.1 -41.5 -19.2 -3.1 -1.1 -5.5 72.5
P/S 10-point trend, -19.4% 2.5 3.5 2.2 1.9 8.1 18.6 7.2 13.6 4.4 · · 3.1
P/B 10-point trend, +52.7% 3.2 3.1 2.4 1.4 5.2 12.9 9.3 10.8 -34.5 · · 2.1
P / Tangible Book 6-point trend, -75.7% 4.2 3.9 3.5 1.7 6.4 17.1 · · · · · ·
P / Cash Flow 10-point trend, +189.3% 22.8 30.8 -33.6 -24.2 -124.8 107.1 -331.1 -259.7 -14.8 · · -25.5
P / FCF 3-point trend, -721.6% · · · · · · · -172.2 -14.6 · · -21.0
EV / EBITDA 5-point trend, -533.6% · · · · · -149.0 -35.8 -62.6 -11.3 · · 34.4
EV / FCF 3-point trend, -988.9% · · · · · · · -161.5 -15.8 · · -14.8
EV / Revenue 5-point trend, +687.6% · · · · · 17.5 6.9 12.7 4.7 · · 2.2
Earnings Yield 12-point trend, -253.6% -2.1% 4.3% -29.5% -12.6% -1.3% -0.55% -2.4% -5.2% -32.4% -88.5% -18.1% 1.4%

Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años

Estado de resultados
2025-12-312024-12-312023-12-312022-12-312021-12-31
Ingresos $380M$334M$280M$322M$296M
Margen Operativo % -8.1%12.2%-72.5%-24.0%-10.0%
Beneficio neto $-21M$53M$-190M$-77M$-31M
EPS Diluido $-0.40$0.93$-3.54$-1.44$-0.59
Balance general
2025-12-312024-12-312023-12-312022-12-312021-12-31
Ratio corriente 2.93.94.05.15.6
Ratio Rápido 2.43.63.74.75.3

Últimas noticias Noticias recientes que mencionan a esta empresa

Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos

📊

Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.

Tu selección se guarda y te sigue en todos los tickers.